Progesterone receptor activation of extranuclear signaling pathways in regulating p53 expression in vascular endothelial cells

Molecular Endocrinology

Volumn 25, Issue 3, 2011, Pages 421-432

  Hsu, Sung Po ^a   Lee, Wen Sen ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANTISENSE OLIGONUCLEOTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; K RAS PROTEIN; MESSENGER RNA; MIFEPRISTONE; PROGESTERONE RECEPTOR; PROTEIN P53; PROTEIN TYROSINE KINASE INHIBITOR; THYMIDINE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME BINDING; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULAR ENDOTHELIUM;

BLOTTING, WESTERN; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; ENDOTHELIAL CELLS; HUMANS; IMMUNOPRECIPITATION; PROGESTERONE; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952168739     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0424     Document Type: Article

References (31)

1. Folkman J, Shing Y 1992 Angiogenesis. J Biol Chem 267:10931-10934
2. Risau W 1997 Mechanisms of angiogenesis. Nature 386:671-674 (Pubitemid 27193480)
3. Polverini PJ 1995 The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 6:230-247
4. Papetti M, Herman IM 2002 Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 282:C947-C970 (Pubitemid 34663101)
5. Zygmunt M, Herr F, Münstedt K, Lang U, Liang OD 2003 Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol 110:S10-S18 (Pubitemid 37074857)
6. Plendl J 2000 Angiogenesis and vascular regression in the ovary. Anat Histol Embryol 29:257-266
7. Girling JE, Rogers PA 2005 Recent advances in endometrial angiogenesis research. Angiogenesis 8:89-99 (Pubitemid 41712839)
8. Graham JD, Clarke CL 1997 Physiological action of progesterone in target tissues. Endocr Rev 18:502-519 (Pubitemid 27349554)
9. Vázquez F, Rodríguez-Manzaneque JC, Lydon JP, Edwards, DP, O'Malley BW, Iruela-Arispe ML 1999 Progesterone regulates proliferation of endothelial cells. J Biol Chem 274:2185-2192
10. Hsu SP, Ho PY, Juan SH, Liang YC, Lee WS 2008 Progesterone inhibits human endothelial cell proliferation through a p53-dependent pathway. Cell Mol Life Sci 65:3839-3850
11. Shupnik MA 2004 Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation. Oncogene 23:7979-7989 (Pubitemid 39480682)
12. Boonyaratanakornkit V, McGowan E, Sherman L, Mancini MA, Cheskis BJ, Edwards DP 2007 The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle. Mol Endocrinol 21:359-375 (Pubitemid 46184890)
13. Meyer C, Schmid R, Scriba PC, Wehling M 1996 Purification and partial sequencing of high-affinity progesterone-binding site(s) from porcine liver membranes. Eur J Biochem 239:726-731 (Pubitemid 26253047)
14. Falkenstein E, Meyer C, Eisen C, Scriba PC, Wehling M 1996 Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. Biochem Biophys Res Commun 229:86-89 (Pubitemid 27013713)
15. Gerdes D, Wehling M, Leube B, Falkenstein E 1998 Cloning and tissue expression of two putative steroid membrane receptors. Biol Chem 379:907-911 (Pubitemid 28369381)
16. Nölte I, Jeckel D, Wieland FT, Sohn K 2000 Localization and topology of ratp28, a member of a novel family of putative steroid-binding proteins. Biochim Biophys Acta 1543:123-130
17. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240:889-895
18. Gellersen B, Fernandes MS, Brosens JJ 2009 Non-genomic progesterone actions in female reproduction. Hum Reprod Update 15:119-138
19. Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL, Miller WT, Edwards DP 2001 Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 8:269-280 (Pubitemid 32831545)
20. Boonyaratanakornkit V, Bi Y, Rudd M, Edwards DP 2008 The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression. Steroids 73:922-928
21. Honda R, Yasuda H 1999 Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J 18:22-27 (Pubitemid 29005019)
22. Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM 2000 Mdm2is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 275:8945-8951 (Pubitemid 30180252)
23. Boggs K, Reisman D 2007 C/EBPβ participates in regulating transcription of the p53 gene in response to mitogen stimulation. J Biol Chem 282:7982-7990 (Pubitemid 47093547)
24. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J, Sukumar S 2000 Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405:974-978 (Pubitemid 30435057)
25. Liu DX, Lobie PE 2007 Transcriptional activation of p53 by Pitx1. Cell Death Differ 14:1893-1907 (Pubitemid 350011665)
26. Benoit V, Hellin AC, Huygen S, Gielen J, Bours V, Merville MP 2000 Additive effect between NF-κB subunits and p53 protein for transcriptional activation of human p53 promoter. Oncogene 19:4787-4794
27. Llanos S, Efeyan A, Monsech J, Dominguez O, Serrano M 2006 A high-throughput loss-of-function screening identifies novel p53 regulators. Cell Cycle 5:1880-1885 (Pubitemid 44435334)
28. Halaschek-Wiener J, Wacheck V, Kloog Y, Jansen B 2004 Ras inhibition leads to transcriptional activation of p53 and down-regulation of Mdm2: two mechanisms that cooperatively increase p53 function in colon cancer cells. Cell Signal 16:1319-1327 (Pubitemid 39165460)
29. Agarwal ML, Ramana CV, Hamilton M, Taylor WR, DePrimo SE, Bean LJ, Agarwal A, Agarwal MK, Wolfman A, Stark GR 2001 Regulation of p53 expression by the RAS-MAP kinase pathway. Oncogene 20:2527-2536 (Pubitemid 32531349)
30. Reisman D, Greenberg M, Rotter V 1988 Human p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within intron 1. Proc Natl Acad Sci USA 85:5146-5150
31. Marzia M, Sims NA, Voit S, Migliaccio S, Taranta A, Bernardini S, Faraggiana T, Yoneda T, Mundy GR, Boyce BF, Baron R, Teti A 2000 Decreased cSrc expression enhances osteoblast differentiation and bone formation. J Cell Biol 151:311-320